{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nThe studies provided focus on the role of SNIP1, a protein that is critical for maintaining intestinal epithelial homeostasis. In the first study, SNIP1 was shown to be markedly decreased in intestinal epithelial cells of inflammatory bowel disease (IBD) patients. This reduction was associated with impaired barrier function—evidenced by a decline in transepithelial electrical resistance and increased paracellular permeability—and an upregulation of NF‐κB p65 activity together with proinflammatory cytokine production. Notably, restoring SNIP1 levels, either by overexpression or exogenous supplementation, ameliorated mucosal inflammation and barrier damage in experimental colitis models."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "In the second study, SNIP1 emerged as a key regulatory node in intestinal fibrosis associated with Crohn’s disease. Here, the long non-coding RNA MSC-AS1 was found to be upregulated in diseased intestinal tissue and contributed to fibrosis by promoting epithelial-mesenchymal transition (EMT). MSC-AS1 exerted its pro-fibrotic effect by interacting with SENP1, which in turn blocked the deSUMOylation of SNIP1 and inhibited its activity. Conversely, SENP1 enhanced SNIP1 expression and countered the fibrotic process, thus implicating a critical regulatory axis in the progression of intestinal fibrosis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "It is important to note that although the query mentions DPY19L2P2, neither abstract directly addresses DPY19L2P2. Instead, they detail the functions of SNIP1 in regulating inflammation, barrier integrity, and fibrotic remodeling in the gut. The findings highlight that modulating SNIP1—whether by directly targeting its expression or its regulatory partners such as MSC-AS1 and SENP1—could offer promising therapeutic avenues for both IBD and Crohn’s disease–associated fibrosis.\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Y Shi, C He, C Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Smad nuclear interacting protein 1 (SNIP1) inhibits intestinal inflammation through regulation of epithelial barrier function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mucosal Immunol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/mi.2017.95"}], "href": "https://doi.org/10.1038/mi.2017.95"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29426045"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29426045"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Wei Chen, Zeyan Xu, Jingjing Jiang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA MSC-AS1 regulates SNIP1 SUMOylation-mediated EMT by binding to SENP1 to promote intestinal fibrosis in Crohn's disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Biol Macromol (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ijbiomac.2024.129921"}], "href": "https://doi.org/10.1016/j.ijbiomac.2024.129921"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38309408"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38309408"}]}]}]}